Javier Gomez-Vera
Overview
Explore the profile of Javier Gomez-Vera including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
62
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Larenas-Linnemann D, Rodriguez-Perez N, Luna-Pech J, Rodriguez-Gonzalez M, Blandon-Vijil M, Del-Rio-Navarro B, et al.
World Allergy Organ J
. 2020 Sep;
13(8):100444.
PMID: 32884611
Background: Allergen immunotherapy (AIT) has a longstanding history and still remains the only disease-changing treatment for allergic rhinitis and asthma. Over the years 2 different schools have developed their strategies:...
2.
Ivancevich J, Cardona V, Larenas-Linnemann D, Mullol J, Neffen H, Zernotti M, et al.
Rev Alerg Mex
. 2020 Feb;
66(4):409-425.
PMID: 32105425
The health and economic impact of allergic diseases are increasing rapidly, and changes in management strategies are required. Its influence reduces the capacity of work and school performance by at...
3.
Larenas-Linnemann D, Luna-Pech J, Rodriguez-Perez N, Rodriguez-Gonzalez M, Arias-Cruz A, Blandon-Vijil M, et al.
Rev Alerg Mex
. 2019 Jun;
66 Suppl 1:1-105.
PMID: 31200597
Background: In Mexico, allergen immunotherapy (AIT) and immunotherapy with hymenoptera venom (VIT) is traditionally practiced combining aspects of the European and American school. In addition, both types of extracts (European...
4.
Larenas-Linnemann D, Mullol J, Ivancevich J, Anto J, Cardona V, Dedeu T, et al.
Rev Alerg Mex
. 2019 Jun;
66(2):263-268.
PMID: 31200425
Although there are high quality clinical guidelines about allergic rhinitis, many patients receive deficient treatment, partly due to the high level of self-medication. MASK (Mobile Airways Sentinel Network) is an...
5.
Rincon-Perez C, Larenas-Linnemann D, Figueroa-Morales M, Luna-Pech J, Garcia-Hidalgo L, Macias-Weinmann A, et al.
Rev Alerg Mex
. 2018 Oct;
65 Suppl 2:s8-s88.
PMID: 30278478
Background: The diagnostic approaches and therapeutic strategies of atopic dermatitis (AD) are generally inconsistent among physicians and health institutions. Objective: To develop a consensus statement among experts to reduce the...
6.
Larenas-Linnemann D, Salas-Hernandez J, Vazquez-Garcia J, Ortiz-Aldana I, Fernandez-Vega M, Del Rio-Navarro B, et al.
Rev Alerg Mex
. 2017 Apr;
64 Suppl 1:s11-s128.
PMID: 28441001
Background: The need for a national guideline, with a broad basis among specialists and primary care physicians was felt in Mexico, to try unifying asthma management. As several high-quality asthma...
7.
Gomez-Vera J, Gutierrez-Avila S, Acosta-Gutierrez D, Lopez-Tiro J, Bedolla-Barajas M
Ann Allergy Asthma Immunol
. 2016 Jul;
117(2):204-6.
PMID: 27369651
No abstract available.
8.
Larenas-Linnemann D, Medina-Avalos M, Ortega-Martell J, Beirana-Palencia A, Rojo-Gutierrez M, Morales-Sanchez M, et al.
Rev Alerg Mex
. 2015 Mar;
61 Suppl 2:S118-93.
PMID: 25724222
Background: Urticaria is a disease that a fifth of the population shallsuffer once in a lifetime. Recent clinical guidelines have proposed some fundamental changes in the diagnosis and treatment of...
9.
Ramirez-Del-Pozo M, Gomez-Vera J, Lopez-Tiro J
Rev Alerg Mex
. 2013 Sep;
59(4):199-203.
PMID: 24008029
Background: The atopic march is characterized by the sequential presence of food allergy, atopic dermatitis, rhinitis and asthma. Risk factors for the progression of the allergic disease defined as atopic...
10.
Cordova E, Jimenez-Morales S, Centeno F, Martinez-Hernandez A, Martinez-Aguilar N, Del-Rio-Navarro B, et al.
Rev Invest Clin
. 2012 Feb;
63(4):407-11.
PMID: 22364041
Introduction: Environmental factors causing oxidative stress are known to be associated with asthma morbidity. The antioxidative gene NFE2L2 has been implicated in asthma development in mice models. In humans, the...